Prostate Cancer Guidelines

Guidelines on Prostate Cancer
A. Heidenreich (chairman), P.J. Bastian, J. Bellmunt, M. Bolla, S. Joniau, M.D. Mason, V. Matveev, N. Mottet, T.H. van der Kwast, T. Wiegel, F. Zattoni
European Association of Urology (EAU) 2012

Guideline for the Early Detection of Prostate Cancer
Andrew M. D. Wolf, MD, Richard C. Wender, MD, Ruth B. Etzioni, PhD, Ian M. Thompson, MD, Anthony V. D'Amico, MD, PhD, Robert J. Volk, PhD, Durado D. Brooks, MD, MPH, Chiranjeev Dash, MD8, Idris Guessous, MD, Kimberly Andrews, Carol DeSantis, MPH, Robert A. Smith, PhD
American Cancer Society 2012

Prostate Cancer Treatment (PDQ®)
National Cancer Institute (NCI) 2012

Adjuvant Radiotherapy Following Radical Prostatectomy for Pathologic T3 or Margin-Positive Prostate Cancer
S.C. Morgan, C. Walker-Dilks, L.J. Eapen, E.W. Winquist, J.L. Chin, D.A. Loblaw, and Members of the Genitourinary Cancer Disease Site Group
Cancer Care Ontario (CCO) 2010

Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update (Reviewed and validity confirmed 2011)
Ian Thompson, M.D., Chair, James Brantley Thrasher, M.D., Co-Chair, Gunnar Aus, M.D., Arthur L. Burnett, M.D., Edith D. Canby-Hagino, M.D., Michael S. Cookson, M.D., Anthony V. D’Amico, M.D., Ph.D., Roger R. Dmochowski, M.D., David T. Eton, Ph.D., Jeffrey D. Forman, M.D., S. Larry Goldenberg, O.B.C., M.D., Javier Hernandez, M.D., Celestia S. Higano, M.D., Stephen R. Kraus, M.D., Judd W. Moul, M.D., Catherine M. Tangen, Dr. P.H.,
American Urological Association (AUA) 2007

Prostate-Specific Antigen Best Practice Statement
Peter Carroll, MD, Chair; Peter C. Albertsen, MD, Vice Chair; Kirsten Greene, MD, Facilitator; Richard J. Babaian, MD; H. Ballentine Carter, MD; Peter H. Gann, MD, ScD; Misop Han, MD; Deborah Ann Kuban, MD; A. Oliver Sartor, MD; Janet L. Stanford, MPH, PhD; Anthony Zietman, MD
American Urological Association (AUA) 2009

Clinical Guidelines Prostate Cancer (CG58) (Reviewed 2011)
Professor Mark Baker, Chair; Dr John Graham, GDG Lead Clinician; Philip Barnard, Angela Billington, Dr Brendan Carey, Mr David Gillatt, Jane Gosling, Dr Chris Hiley, Margaret Jewitt, Mr John McLoughlin, Dr Chris Parker, John Rawlinson, Professor David Weller, Dr John Wiles.
National Institute for Health and Clinical Excellence (NICE) 2008

Guideline for Optimization of Surgical and Pathological Quality Performance for Radical Prostatectomy in Prostate Cancer Management
J. Chin, J. Srigley, L.A. Mayhew, R.B. Rumble, C. Crossley, A. Hunter, N. Fleshner, B. Bora, R. McLeod, S. McNair, B. Langer, A. Evans, and the Expert Panel on Prostate Cancer Surgery and Pathology
Cancer Quality Council of Ontario (CQCO) 2008

Use of 5-alpha Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology-American Urological Association 2008 Clinical Practice Guideline (2012 Update)
Barnett S. Kramer, Karen L. Hagerty, Stewart Justman, Mark R. Somerfield, Peter C. Albertsen, William J. Blot, H. Ballentine Carter, Joseph P. Costantino, Jonathan I. Epstein, Paul A. Godley, Russell P. Harris, Timothy J. Wilt, Janet Wittes, Robin Zon, and Paul Schellhammer
American Society of Clinical Oncology (ASCO) 2009

High-intensity Focused Ultrasound for Prostate Cancer
H. Lukka, T. Waldron, J. Chin, L. A. Mayhew, P. Warde, E. Winquist, G. Rodrigues, B. Shayegan, and Members of the Genitourinary Cancer Disease Site Group
Cancer Care Ontario (CCO) 2009

SCA Clinical Practice Guideline for Prostate Cancer
Dr. Ali El-Gayed, Dr. Evgeny Sadikov, Dr. D. Drachenberg, Dr. A. Dubey, Dr. S. Hotte, Dr. R. Koul, Dr. K. Pauw, Dr. D. Skarsgard, Dr. P. Tai, Dr. Jon Tonita, Dr. E. Tse, Dr. K. Visvanathan
Saskatchewan Cancer Agency (SCA) 2008

National Guideline Clearinghouse Clinical Practice Guideline for Prostate Cancer Treatment
Antonio Antón Torres, Specialist in Medical Oncology, "Miguel Servet" University Hospital, Zaragoza; Ángel Borque Fernando, Specialist in Urology, "Miguel Servet" University Hospital, Zaragoza; Verónica Calderero Aragón, Specialist in Medical Oncology, "Miguel Servet" University Hospital, Zaragoza; Ricardo Escó Barón, Specialist in Radiotherapeutic Oncology, "Lozano Blesa", University Clinical Hospital, Zaragoza; Elvira Elena García Álvarez, Specialist in Preventive Medicine and Public Health, Aragon Institute of Health Sciences, Zaragoza; Mª Jesús Gil Sanz, Specialist in Urology, "Miguel Servet" University Hospital, Zaragoza; Mercedes Martín Valenciano, Nurse, "Miguel Servet" University Hospital, Zaragoza; Agustina Méndez Villalón, Specialist in Radiotherapeutic Oncology, "Miguel Servet" University Hospital, Zaragoza; Luis Plaza Mas, Specialist in Pathological Anatomy, "Miguel Servet" University Hospital, Zaragoza; Luis Ángel Rioja Sanz, Specialist in Urology, "Miguel Servet" University Hospital, Zaragoza; Alberto Sáenz Cusí, Specialist in Medical Oncology, "Lozano Blesa" University Clinical Hospital, Zaragoza; Martín Tejedor Gutiérrez, Specialist in Radiotherapeutic Oncology, "Miguel Servet" University Hospital, Zaragoza; Carmen Velilla Millán, Specialist in Radiotherapeutic Oncology, "Lozano Blesa" University Clinical Hospital, Zaragoza
Agency for Healthcare Research and Quality (AHRQ) 2010

NETS Module 10: Bladder, Prostate, and Testicular Malignancies
Prepared by Scientific Applications International Corporation (SAIC)
Centers for Disease Control and Prevention (CDC) 2009

ACR–ASTRO Practice Guideline for Transperineal Permanent Brachytherapy of Prostate Cancer
ACR:Seth A. Rosenthal, MD, FACR, Chair; Nathan H.J. Bittner, MD; Brian J. Goldsmith, MD; Geoffrey S. Ibbott, PhD, FACR; W. Robert Lee, MD ASTRO:David C. Beyer, MD, FACR;D. Jeffrey Demanes, MD, FACR;Louis Potters, MD, FACR; Subir Nag, MD, FACR; Warren Suh, MD, MPH; ABS:Eric M. Horwitz, MD
American College of Radiology (ACR) 2010